Articles

ARMO

ILLUMINA

Purepoint Uranium Completes Winter Program at Hook Lake Project

Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas

Purepoint Uranium Completes Winter Program at Hook Lake Project

FDA advisors back approval of GW’s Epidiolex

Digirad Corporation to Release 2018 First Quarter Financial Results on May 1, 2018

Allergan à l'extérieur mais Takeda colle aux armes sur Shire | Pharmafile

BONJOUR

ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN

Hello en pause